IRIS
VENERITO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.241
AS - Asia 1.445
EU - Europa 983
SA - Sud America 350
AF - Africa 66
OC - Oceania 3
Totale 5.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.174
SG - Singapore 730
BR - Brasile 313
CN - Cina 252
HK - Hong Kong 219
RU - Federazione Russa 216
IT - Italia 189
SE - Svezia 157
DE - Germania 100
VN - Vietnam 79
GB - Regno Unito 74
FR - Francia 58
FI - Finlandia 54
CA - Canada 40
IN - India 40
ID - Indonesia 29
JP - Giappone 28
CI - Costa d'Avorio 26
MX - Messico 20
NL - Olanda 20
ZA - Sudafrica 18
BE - Belgio 17
AT - Austria 15
BD - Bangladesh 15
AR - Argentina 14
CZ - Repubblica Ceca 13
LT - Lituania 13
PL - Polonia 13
ES - Italia 12
PK - Pakistan 11
IQ - Iraq 10
UA - Ucraina 10
TR - Turchia 8
EC - Ecuador 6
CO - Colombia 5
IR - Iran 5
MA - Marocco 5
DK - Danimarca 4
DZ - Algeria 4
VE - Venezuela 4
AU - Australia 3
BB - Barbados 3
IE - Irlanda 3
KE - Kenya 3
KZ - Kazakistan 3
SN - Senegal 3
TN - Tunisia 3
UZ - Uzbekistan 3
EE - Estonia 2
EG - Egitto 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
LU - Lussemburgo 1
MD - Moldavia 1
MW - Malawi 1
PH - Filippine 1
SI - Slovenia 1
TL - Timor Orientale 1
TW - Taiwan 1
Totale 5.088
Salva come PNG Salva come JPEG
Città #
Singapore 394
Ashburn 349
Hong Kong 216
Chandler 199
Fairfield 183
Nyköping 136
Beijing 134
Dallas 100
Woodbridge 81
Houston 80
Cambridge 73
Seattle 67
New York 60
Los Angeles 59
Munich 55
Wilmington 52
Ann Arbor 43
Bari 39
Moscow 39
Ho Chi Minh City 36
Lawrence 32
Roxbury 30
Helsinki 27
São Paulo 27
Turku 27
Abidjan 26
Inglewood 25
Jakarta 22
Santa Clara 22
Buffalo 21
Jacksonville 21
Tokyo 21
Des Moines 19
London 18
Brussels 17
Chicago 15
Johannesburg 15
Montreal 15
Brooklyn 14
Pune 14
Toronto 13
Belo Horizonte 12
Mexico City 12
Milan 12
Denver 11
Hanoi 10
Warsaw 10
Atlanta 9
Brno 9
Frankfurt am Main 9
Manchester 9
Nuremberg 9
San Diego 9
San Francisco 9
Chennai 8
Poplar 8
Campinas 7
Council Bluffs 7
Falkenstein 7
Nanjing 7
Paris 7
Rio de Janeiro 7
Shanghai 7
Stockholm 7
Boston 6
Brasília 6
Columbus 6
Florence 6
Goiânia 6
Guarulhos 6
Redwood City 6
Salt Lake City 6
Ankara 5
Brindisi 5
Charlotte 5
Dhaka 5
Roubaix 5
Shenyang 5
Taranto 5
The Dalles 5
Vienna 5
Casablanca 4
Dearborn 4
Dong Ket 4
Elk Grove Village 4
Guangzhou 4
Hounslow 4
Lahore 4
Lauterbourg 4
Modugno 4
Mumbai 4
Naples 4
Orem 4
Ottawa 4
Phoenix 4
Porto Alegre 4
Rome 4
Wuhan 4
Ardabil 3
Augusta 3
Totale 3.205
Salva come PNG Salva come JPEG
Nome #
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 160
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 157
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 153
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 144
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 138
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 125
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 110
A machine learning tool to predict the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer 110
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 107
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 104
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 101
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 100
Formalin-fixed and paraffin-embedded samples for next generation sequencing: Problems and solutions 96
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 95
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 91
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 87
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 86
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study 82
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 82
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 82
A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab 81
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 79
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 79
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 78
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 76
Complete Hydatidiform Mole Mimicking Sacroiliitis 75
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 73
null 71
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis 71
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 70
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 70
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 70
Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23 68
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 68
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 67
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 66
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 66
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 66
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 61
Unraveling the microbiome-metabolome nexus: a comprehensive study protocol for personalized management of Behḉet’s disease using explainable artificial intelligence 61
Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI) 60
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 59
Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy 58
Safety of systemic treatments for Behçet’s syndrome 58
Radiomics analysis in ovarian cancer: A narrative review 58
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 55
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 54
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 53
Letters to the editors 52
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 50
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast 49
Efficacité de l'anakinra dans la polysérite réfractaire : étude multicentrique italienne 48
AI am a rheumatologist: A practical primer to large language models for rheumatologists 46
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 44
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet’s disease 44
Cytokine signatures in mucocutaneous and Ocular Behçet's disease 43
Management of takayasu arteritis diagnosed during pregnancy: A case report 43
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 42
COVID-19 Vaccine Knowledge, Attitude, Acceptance and Hesitancy among Pregnancy and Breastfeeding: Systematic Review of Hospital-Based Studies 41
Reply to Praprotnik and Tomsic and erratum corrige 41
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 41
Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an ai approach 41
Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF) 40
The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis 40
Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study 40
COVAD survey 2 long-term outcomes: unmet need and protocol 37
Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium” 37
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 36
COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence 35
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 35
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study 30
Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study 29
Safety of abatacept in Italian patients with rheumatoid arthritis and interstitial lung disease: A multicenter retrospective study 29
Predictors of long-term clinical remission in rheumatoid arthritis 27
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 25
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 25
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 24
Uncovering the Underworld of Axial Spondyloarthritis 24
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 23
Prompt engineering: The next big skill in rheumatology research 23
null 22
Integrating large language models in medicine: a study of Claude 2’s performance in MDAAT scoring for idiopathic inflammatory myopathies 19
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 18
Update on the Medical Management of Gastrointestinal Behçet's Disease 16
Harnessing the potential of digital rheumatology 14
Beyond the horizon: Innovations and future directions in axial-spondyloarthritis 9
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 7
Concomitant inflammatory bowel disease impairs biologic response and increases residual symptom burden in psoriatic arthritis 7
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al‘ by Agca et al 7
The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations 5
Editorial: New insights into spondyloarthritis: from bench to bedside 2
Totale 5.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021208 0 0 0 0 0 29 35 39 23 34 29 19
2021/2022264 9 5 5 8 10 22 23 10 22 35 46 69
2022/2023589 48 86 32 32 41 111 13 83 92 4 33 14
2023/2024320 22 55 18 28 29 67 5 27 3 13 5 48
2024/20251.622 45 29 60 29 34 141 192 260 68 119 217 428
2025/20261.795 498 149 277 397 437 37 0 0 0 0 0 0
Totale 5.391